Display options
Cite
Yavuz DG, Bilen H, Sancak S, et al. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016;10:851-61doi: 10.2147/PPA.S100626.
Yavuz, D. G., Bilen, H., Sancak, S., Garip, T., Hekimsoy, Z., Sahin, I., Yilmaz, M., Aydin, H., Atmaca, A., Sert, M., Karakaya, P., Arpaci, D., Oguz, A., & Guvener, N. (2016). Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient preference and adherence, 10851-61. https://doi.org/10.2147/PPA.S100626
Yavuz, Dilek Gogas, et al. "Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study." Patient preference and adherence vol. 10 (2016): 851-61. doi: https://doi.org/10.2147/PPA.S100626
Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016. PMID: 27274207; PMCID: PMC4876103.
Copy Download .nbib Format: NLM
Share it on

Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016.

Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study.

Patient preference and adherence

Dilek Gogas Yavuz, Habip Bilen, Seda Sancak, Tayfun Garip, Zeliha Hekimsoy, Ibrahim Sahin, Murat Yilmaz, Hasan Aydin, Aysegul Atmaca, Murat Sert, Pinar Karakaya, Dilek Arpaci, Aytekin Oguz, Nilgun Guvener

Affiliations

  1. Department of Endocrinology and Metabolism, Marmara University Faculty of Medicine, Istanbul, Turkey.
  2. Department of Endocrinology and Metabolism, Ataturk University Faculty of Medicine, Erzurum, Turkey.
  3. Clinic of Endocrinology and Metabolism, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
  4. Clinic of Endocrinology and Metabolism, Sakarya State Hospital, Sakarya, Turkey.
  5. Department of Endocrinology and Metabolism, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
  6. Department of Endocrinology and Metabolism, Inonu University Faculty of Medicine, Malatya, Turkey.
  7. Department of Endocrinology and Metabolism, Nam?k Kemal University Faculty of Medicine, Tekirdag, Turkey.
  8. Department of Endocrinology and Metabolism, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
  9. Department of Endocrinology and Metabolism, Ondokuzmay?s University Faculty of Medicine, Samsun, Turkey.
  10. Department of Endocrinology and Metabolism, Cukurova University Faculty of Medicine, Adana, Turkey.
  11. Clinic of Endocrinology and Metabolism, Bak?rkoy Training and Research Hospital, Istanbul, Turkey.
  12. Department of Internal Medicine, Medeniyet University Faculty of Medicine, Istanbul, Turkey.
  13. Department of Endocrinology and Metabolism, Baskent University Faculty of Medicine, Istanbul, Turkey.

PMID: 27274207 PMCID: PMC4876103 DOI: 10.2147/PPA.S100626

Abstract

OBJECTIVE: The objective of this study is to evaluate the impact of sequential telephonic interviews on treatment persistence and daily adherence to insulin injections among insulin-naïve type 2 diabetes patients initiated on different insulin regimens in a 3-month period.

METHODS: A total of 1,456 insulin-naïve patients with type 2 diabetes (mean [standard deviation, SD] age: 56.0 [12.0] years, 49.1% were females) initiated on insulin therapy and consecutively randomized to sequential (n=733) and single (n=723) telephonic interview groups were included. Data on insulin treatment and self-reported blood glucose values were obtained via telephone interview. Logistic regression analysis was performed for factors predicting increased likelihood of persistence and skipping an injection.

RESULTS: Overall, 76.8% patients (83.2% in sequential vs 70.3% in single interview group, (P<0.001) remained on insulin treatment at the third month. Significantly higher rate for skipping doses was noted in basal bolus than in other regimens (27.0% vs 15.0% for premixed and 15.8% basal insulin, respectively, P<0.0001). Logistic regression analysis revealed sequential telephonic interview (odds ratio [OR], 1.531; 95% confidence interval [CI], 1.093-2.143; P=0.013), higher hemoglobin A1c levels (OR, 1.090; 95% CI, 0.999-1.189; P=0.049), and less negative appraisal of insulin therapy as significant predictors of higher persistence. Basal bolus regimen (OR, 1.583; 95% CI, 1.011-2.479; P=0.045) and higher hemoglobin A1c levels (OR, 1.114; 95% CI, 1.028-1.207; P=0.008) were the significant predictors of increased likelihood of skipping an injection.

CONCLUSION: Our findings revealed positive influence of sequential telephonic interview, although including no intervention in treatment, on achieving better treatment persistence in type 2 diabetes patients initiating insulin.

Keywords: HbA1c; insulin analogs; self-monitoring of blood glucose; type 2 diabetes

References

  1. Diabetes Educ. 2007 Nov-Dec;33(6):1014-29; discussion 1030-1 - PubMed
  2. Diabetes Care. 2010 Feb;33(2):240-5 - PubMed
  3. Diabetes Care. 2002 Feb;25(2):330-6 - PubMed
  4. Curr Med Res Opin. 2007 Dec;23(12):3105-12 - PubMed
  5. Clin Ther. 2003 Nov;25(11):2836-48 - PubMed
  6. Patient Prefer Adherence. 2010 Jun 24;4:147-56 - PubMed
  7. Health Qual Life Outcomes. 2010 Oct 04;8:113 - PubMed
  8. Diabetes Care. 2012 Jun;35(6):1364-79 - PubMed
  9. Diabetes Care. 1999 Oct;22(10):1617-20 - PubMed
  10. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80 - PubMed
  11. Diabet Med. 2012 May;29(5):682-9 - PubMed
  12. J Am Osteopath Assoc. 2013 Apr;113(4 Suppl 2):S6-16 - PubMed
  13. Lancet. 1997 Nov 22;350(9090):1505-10 - PubMed
  14. Diabetes Care. 2009 Nov;32 Suppl 2:S217-22 - PubMed
  15. Diabetes Obes Metab. 2011 Dec;13(12):1142-8 - PubMed
  16. J Am Osteopath Assoc. 2010 Feb;110(2):69-78 - PubMed
  17. Int J Clin Pract. 2011 May;65(5):602-12 - PubMed
  18. Endocr Pract. 2009 Sep-Oct;15(6):540-59 - PubMed
  19. Diabetes Technol Ther. 2012 Aug;14(8):741-7 - PubMed
  20. Diabetes Metab Res Rev. 2012 Jan;28(1):97-105 - PubMed
  21. Ann Fam Med. 2006 Jan-Feb;4(1):23-31 - PubMed
  22. Patient Prefer Adherence. 2015 Aug 25;9:1225-31 - PubMed
  23. Clin Ther. 2001 Aug;23(8):1311-20 - PubMed
  24. Diabetes Care. 2004 May;27(5):1218-24 - PubMed
  25. J Multidiscip Healthc. 2014 Jul 02;7:267-82 - PubMed
  26. Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S97-9 - PubMed
  27. Int J Clin Pract. 2010 Nov;64(12):1609-18 - PubMed
  28. Diabetes Obes Metab. 2013 Dec;15(12):1120-7 - PubMed
  29. Diabetes Care. 2010 Apr;33(4):733-5 - PubMed

Publication Types